F-1: Meiwu Technology F-1: Skincare & Bitcoin Strategy

Meiwu Technology Company Limited files an F-1 registration for a $0.80 per share offering, pivoting to functional skincare and a significant bitcoin treasury strategy.

Summary

• A primary offering of up to 38,000,000 ordinary shares is being made at a fixed public offering price of $0.80 per share.
• Chairman Changbin Xia is offering to resell 12,000,000 ordinary shares at $0.80 per share, from which the company will not receive any proceeds.
• The company is a British Virgin Islands holding company with primary operations in China through its subsidiaries, notably Xiamen Chunshang.
• A strategic business transition is underway to focus on functional skincare products, which accounted for 94.6% of total revenue in H1 2025 and 38% in FY 2024.
• Approximately 50% of the net proceeds from the primary offering are planned for bitcoin investment, with an objective to maintain an average cost basis below $115,000 per bitcoin.
• The company reported a net loss of $1.36 million in H1 2025, following net losses of $16.31 million in FY 2023 and $11.22 million in FY 2022.
• A net income of $5.11 million was reported in FY 2024, primarily driven by an $8.22 million gain on the disposal of subsidiaries.
• Net revenue significantly increased to $2.48 million in H1 2025 from $0.09 million in H1 2024, largely due to the new functional skincare business.
• Gross profit rose to $0.32 million in H1 2025 from $0.04 million in H1 2024, but the gross margin decreased from 51% to 13% in the same period.
• Sales and marketing expenses surged by 1154% in H1 2025 to $0.8 million, reflecting increased promotional activities for the new business.
• The company is classified as an 'emerging growth company' and a 'foreign private issuer' under U.S. federal securities laws.
• Chairman Changbin Xia beneficially owned 86.35% of outstanding shares prior to the offering.

Sentiment

Score: 3

Explanation: The company is undergoing a significant and risky business pivot from food e-commerce/SMS services to functional skincare and a substantial bitcoin treasury strategy, both highly competitive and volatile sectors. Despite a recent revenue surge in the new skincare segment, the company has a history of significant net losses, and the 2024 net income was primarily due to asset disposals rather than core operational profitability. The plan to allocate 50% of offering proceeds to bitcoin, a highly volatile and unregulated asset, introduces extreme financial risk. Furthermore, the identified material weakness in internal controls, coupled with the inherent regulatory and geopolitical risks of operating in China as a BVI holding company, creates substantial uncertainty. The best-efforts offering with no minimum further highlights potential funding shortfalls.

Positives

• The strategic pivot to functional skincare has shown significant revenue growth, with net product revenue increasing from $86,159 in H1 2024 to $2,344,583 in H1 2025.
• Plans to invest approximately 50% of net proceeds into Bitcoin could leverage potential appreciation in digital assets, diversifying corporate cash holdings.
• Active engagement in R&D for skincare products, including cooperation agreements with Meixing Biology Research Institute and Guangdong Daao Biotechnology Research Institute for new formulations.
• Acquisition of multiple trademarks and patents for skincare formulations (e.g., MQIANS, Chunran, Aishuli, GF ZHIYE) strengthens intellectual property in the new business segment.
• Strategic initiative to establish a network of over 1,500 offline affiliate stores and conduct extensive online marketing campaigns to expand market coverage and brand influence.
• Maintained a strong cash position of $43,396,977 as of December 31, 2024, providing capital for strategic initiatives.
• The company's current auditor, Enrome LLP, is headquartered in Singapore and is subject to PCAOB inspections, reducing immediate delisting risk under the Holding Foreign Companies Accountable Act (HFCAA).

Negatives

• The company has a history of significant net losses, including $1.36 million in H1 2025, $16.31 million in FY 2023, and $11.22 million in FY 2022, indicating ongoing operational challenges.
• The net income of $5.11 million in FY 2024 was primarily due to an $8.22 million gain on disposal of subsidiaries, masking underlying operational losses.
• Gross profit margin for H1 2025 was 13%, a substantial decrease from 51% in H1 2024, suggesting higher costs relative to revenue in the new skincare business.
• Heavy reliance on third-party manufacturers for product formulas and production introduces risks related to quality control, intellectual property enforcement, and competitive pricing.
• The beauty industry is highly competitive, with larger multinational companies possessing greater resources and brand recognition, posing significant market share challenges.
• The planned bitcoin treasury strategy exposes the company to extreme price volatility, regulatory uncertainty, and custody risks associated with digital assets.
• Significant legal and operational risks are associated with being based in China, including potential government intervention, evolving regulations, and restrictions on fund transfers.
• An identified material weakness in internal control over financial reporting as of December 31, 2024, due to insufficient in-house US GAAP and SEC reporting expertise, raises concerns about financial accuracy and compliance.
• No dividends are anticipated in the foreseeable future, as the company intends to retain earnings for business expansion, limiting immediate returns for investors.
• The offering is on a 'best-efforts' basis with no minimum purchase requirement, meaning the company may raise substantially less than the maximum proceeds, potentially hindering business goals.
• The company may be classified as a Passive Foreign Investment Company (PFIC) for U.S. federal income tax purposes, which could result in unfavorable tax consequences for U.S. investors.

Risks

• The Chinese government may intervene or influence operations at any time, potentially causing material changes in operations and/or the value of securities.
• Uncertainties exist regarding the interpretation and enforcement of PRC laws, rules, and regulations, which can change quickly with little advance notice.
• Additional compliance procedures may be required for subsequent securities offerings due to new PRC filing-based administrative rules, potentially limiting the ability to offer securities.
• Securities may be prohibited from trading in the United States under the HFCAA if the PCAOB is unable to inspect or investigate the auditor for two consecutive years.
• Recent greater oversight by the Cyberspace Administration of China (CAC) over data security, particularly for companies seeking to list on a foreign exchange, could adversely impact the business.
• Reliance on dividends and other distributions from PRC subsidiaries to fund cash and financing requirements, with potential limitations imposed by PRC regulations on profit distribution and currency conversion.
• Fluctuations in exchange rates (RMB to U.S. dollar) could have a material adverse effect on results of operations and share price.
• The M&A Rules and other PRC regulations establish complex procedures for acquisitions, potentially making it more difficult to pursue growth through acquisitions in China.
• Incurring additional costs as a public company, particularly after ceasing to qualify as an emerging growth company, could negatively impact net income and liquidity.
• The obligation to disclose information publicly may put the company at a disadvantage to private competitors.
• As a foreign private issuer and emerging growth company, disclosure obligations differ from U.S. domestic reporting companies, potentially making it more difficult for investors to evaluate performance.
• Management team will have broad discretion over the use of net proceeds from the offering, and proceeds may not be invested successfully.
• The company operates in a dynamic industry and has a limited operating history in functional skincare, making historical results not indicative of future performance.
• Reliance on formulas provided by third-party manufacturers exposes the company to risks if agreements are not enforced or competitors introduce similar products.
• The beauty industry is highly competitive, and an inability to compete effectively may result in loss of market share.
• Success is dependent on the popularity of products and the ability to anticipate and respond to changes in industry trends and consumer preferences in a timely manner.
• New product introductions may not be as successful as anticipated, materially affecting business and financial results.
• Business depends, in part, on the quality, effectiveness, and safety of products; any loss of confidence could tarnish brand image and lead to recalls or liability claims.
• May not be able to successfully implement growth strategy, including building brand, penetrating markets, and expanding product offerings.
• Higher labor costs could adversely affect business and financial results.
• The bitcoin treasury strategy exposes the company to various risks associated with bitcoin, including extreme volatility, custody risks (loss/destruction of private keys, cyberattacks), and significant legal, commercial, regulatory, and technical uncertainty.
• The availability of spot bitcoin ETPs may adversely affect the market price of Ordinary Shares by offering alternative exposure to bitcoin.
• The bitcoin treasury strategy subjects the company to enhanced regulatory oversight, including potential scrutiny from the SEC or other agencies.
• Due to the unregulated nature and lack of transparency of many bitcoin trading venues, greater fraud, security failures, or operational problems could adversely affect the value of bitcoin holdings.
• The emergence or growth of other digital assets (e.g., stablecoins, CBDCs) could negatively impact the price of bitcoin.
• Bitcoin holdings are less liquid than cash and cash equivalents and may not serve as a reliable source of liquidity during market instability.
• If the company or third-party service providers experience a security breach or cyberattack, some or all bitcoin holdings may be lost.
• Regulatory change reclassifying bitcoin as a security could lead to the company's classification as an investment company under the 1940 Act, adversely affecting bitcoin price and financial conditions.
• Exposure to risk of non-performance by counterparties in bitcoin transactions, particularly custodians, could result in loss of bitcoin.
• Custodially-held bitcoin may become part of the custodian's insolvency estate if a custodian enters bankruptcy, potentially leading to loss of value.
• A temporary or permanent blockchain fork to bitcoin could adversely affect the business.
• Regulatory actions in one or more countries could severely affect the right to acquire, own, hold, sell, or use Bitcoin.
• The regulatory environment regarding digital assets and digital asset mining is in flux, potentially limiting the ability to operate.
• Internal controls over financial reporting may not be effective, and the independent registered public accounting firm may not be able to certify their effectiveness, impacting business and reputation.
• Certain judgments obtained against the company by shareholders may not be enforceable due to British Virgin Islands and PRC laws.
• Difficulty in protecting interests and limited ability to protect rights through U.S. courts due to BVI incorporation.
• There is a risk of being classified as a passive foreign investment company (PFIC) for United States federal income tax purposes, leading to significant adverse tax consequences for U.S. investors.
• The trading price of Ordinary Shares is likely to be volatile, which could result in substantial losses to investors.
• Future issuances or sales, or perceived issuances or sales, of substantial amounts of shares in the public market could materially and adversely affect the prevailing market price and ability to raise capital.

Future Outlook

The company plans to further develop its functional skincare business by expanding partnerships with research institutions for new formulas and establishing a network of distributors in second and third-tier Chinese cities. It intends to allocate approximately 50% of the net proceeds from the primary offering to acquire bitcoin over time, aiming for an average cost basis below $115,000 per bitcoin, as part of a strategic asset allocation for long-term value creation and liquidity. No cash dividends are anticipated in the foreseeable future, with all available funds and future earnings expected to be reinvested for business operation and expansion.

Management Comments

• "We plan to use the net proceeds from the primary offering for the following purposes: approximately 9.5% to conduct online marketing campaigns to enhance exposure of our brand IP Gongfuzhiye (); approximately 28% to establish a network of over 1,500 offline affiliate stores to expand market coverage and influence; approximately 12.5% for working capital and general corporate operating purposes, including, but not limited to, personnel costs associated with recruitment of affiliate stores; and approximately 50% for bitcoins investment."
• "We and our subsidiaries currently intend to retain all available funds and future earnings, if any, for the operation and expansion of our business and do not anticipate declaring or paying any dividends in the foreseeable future."
• "Our management is directly supervising cash management. Our finance department is responsible for establishing the cash management policies and procedures among our departments and the operating entities."
• "We believe we will be able to possess robust capabilities throughout the supply chain of our functional skincare business."
• "We believe that social media will be the engine that fuels our next stage of growth."
• "Our objective, which may change based on market developments, is to maintain an average cost basis of less than approximately US$115,000 per bitcoin for any bitcoin acquired."

Industry Context

The functional skincare industry in China is experiencing robust growth, with a projected CAGR of approximately 5% over the next five years and a market size exceeding RMB 48 billion (USD 6.6 billion) in 2024, driven by increasing consumer demand for ingredient transparency and product efficacy. The beauty training service industry is also expanding, supported by government initiatives in vocational education and the rising demand for skilled professionals in light medical aesthetics. In contrast, the Bitcoin market remains highly volatile and subject to significant regulatory uncertainty, despite the recent approval of spot bitcoin ETPs, which could influence investor interest in direct or indirect bitcoin exposure.

Comparison to Industry Standards

• The functional skincare industry in China is projected to achieve a compound annual growth rate (CAGR) of approximately 5% over the next five years, with its market size exceeding RMB 48 billion (approximately USD 6.6 billion) in 2024, reflecting a remarkable five-year CAGR of 25.25%.
• The market size of light medical aesthetics in China may reach the level of hundreds of billions by 2025, indicating significant growth potential for related training services.
• The company faces competition from established multinational and domestic brands like Winona, Pechoin, and Chando, which benefit from longer operating histories, higher market shares, and economies of scale, potentially allowing them to produce goods at lower costs per unit and maintain greater brand recognition.

Management Changes

Corporate Governance

Legal Proceedings

• As of December 31, 2024, there were no pending legal proceedings to which the Group is a party that will have a material effect on the Group's business, results of operations, or cash flows.

Related Party Transactions

• Amounts due to Eternal Horizon International Company Limited (a former shareholder) were $4,999,550 as of December 31, 2023 (nil as of December 31, 2024).
• The company borrowed interest-free loans as working capital from Chairman Changbin Xia, with balances of $1,287,629 as of December 31, 2024, and $1,410,621 as of December 31, 2023.
• In FY 2023, the company purchased $18,310 in food products from related parties (nil in FY 2024), with an account payable of $15,627 to these parties as of December 31, 2023 (nil as of December 31, 2024).
• Sales to related parties amounted to $21,215 in FY 2023 (nil in FY 2024).
• Mr. Changbin Xia purchased 12,000,000 restricted Ordinary Shares at $0.80 per share on September 5, 2025, in a private placement.

Stakeholder Impact

• Shareholders face potential dilution from the new share offering and future capital raises, significant exposure to the highly volatile bitcoin market, and risks associated with the company's China-based operations and evolving regulatory environment. No dividends are anticipated in the foreseeable future.
• Employees will see increased personnel costs due to the establishment of a new media operations department and recruitment of franchise development staff, indicating growth in employment opportunities.
• Customers can expect new functional skincare products and an expanded network of offline stores, potentially enhancing product accessibility and customer experience.
• Suppliers and manufacturers will continue to be critical partners, particularly third-party manufacturers for skincare products, with potential for increased demand as the business expands.
• Creditors, especially Chairman Changbin Xia who provides interest-free loans, are exposed to the company's historical losses and the inherent risks of its new business strategies, though the capital raise may improve short-term liquidity.

Next Steps

• Conduct online marketing campaigns and incubate livestream e-commerce accounts to enhance exposure of brand IP Gongfuzhiye (9.5% of net proceeds).
• Establish a network of over 1,500 offline affiliate stores to expand market coverage and influence (28% of net proceeds).
• Allocate 12.5% of net proceeds for working capital and general corporate operating purposes, including personnel costs for affiliate store recruitment.
• Purchase bitcoins as part of a strategic asset allocation, using approximately 50% of net proceeds (approximately $20 million).
• Expand partnerships with research institutions to develop new functional skincare formulas and products.
• Complete the transfer of acquired patents for skincare formulations, expected in November 2025.
• Recruit approximately 70 marketing staff and provide internal training on marketing plans and skills.
• Hold approximately 30 business promotion salons per month across various cities in China to recruit and develop affiliate stores.
• Subsidize partners and affiliate stores for the replacement of store signage with standardized Company-branded signage.
• Provide training to partner stores on technical knowledge of functional skincare products and implementation of unified promotional programs.
• Closely monitor PRC regulatory developments relating to cryptocurrency and adjust strategies accordingly to avoid potential non-compliance.
• Implement measures designed to improve internal control over financial reporting to remediate the identified material weakness, including hiring outside financial personnel with US GAAP and SEC reporting experience.

Key Dates

Recommendation

The company is undergoing a significant and risky business pivot from food e-commerce/SMS services to functional skincare and a substantial bitcoin treasury strategy, both highly competitive and volatile sectors. Despite a recent revenue surge in the new skincare segment, the company has a history of significant net losses, and the 2024 net income was primarily due to asset disposals rather than core operational profitability. The plan to allocate 50% of offering proceeds to bitcoin, a highly volatile and unregulated asset, introduces extreme financial risk. Furthermore, the identified material weakness in internal controls, coupled with the inherent regulatory and geopolitical risks of operating in China as a BVI holding company, creates substantial uncertainty. The best-efforts offering with no minimum further highlights potential funding shortfalls. Given the high risk, unproven new business model, historical losses, and significant exposure to volatile assets and regulatory environments, a seasoned investor would likely recommend selling or avoiding this stock.

Keywords

Meiwu Technology, WNW, SEC F-1, Public Offering, Functional Skincare, Bitcoin Investment, China Operations, Holding Company, PRC Regulation, Nasdaq, Emerging Growth Company, Foreign Private Issuer, Corporate Governance, Risk Factors, Financial Performance, Capital Raise, Market Volatility, Cybersecurity, Data Privacy, Intellectual Property, Supply Chain, E-commerce, Offline Stores, Brand IP, Gongfuzhiye, Meixing Biology, Guangdong Daao, Changbin Xia, Shareholder Dilution, PFIC, HFCAA, Auditor Inspection, Cash Flow, Net Loss, Revenue Growth, Asset Impairment, Related Party Transactions